Table 2.
Variable | COVID period group (n = 616) | Reference period group (n = 997) | Standardized mean difference | p value |
Primary outcome | ||||
EQ-5D index score | 0.85 (0.77 to 0.89) | 0.85 (0.77 to 0.89) | 0.035 | 0.98 |
Secondary outcomes | ||||
EQ-5D VAS general health | 86 (71 to 94) | 85 (73 to 93) | 0.005 | 0.90 |
EQ-5D subscale mobility | 1 (1 to 1) | 1 (1 to 1) | 0.006 | 0.92 |
EQ-5D subscale self-care | 1 (1 to 1) | 1 (1 to 1) | 0.014 | 0.76 |
EQ-5D subscale usual activities | 1 (1 to 2) | 2 (1 to 2) | 0.039 | 0.37 |
EQ-5D subscale pain/ discomfort | 2 (1 to 3) | 2 (2 to 3) | 0.059 | 0.19 |
EQ-5D subscale anxiety/ depression | 1 (1 to 1) | 1 (1 to 1) | 0.003 | 0.73 |
VAS hand function | 84 (59 to 96) | 81 (53 to 94) | 0.108 | 0.37 |
VAS mean pain past week | 15 (4 to 40) | 17 (4 to 51) | 0.096 | 0.046 |
VAS pain during rest | 7 (0 to 27) | 7 (0 to 30) | 0.077 | 0.07 |
VAS pain during physical load | 21 (5 to 52) | 23 (6 to 61) | 0.093 | 0.008 |
Reported values per group are medians (interquartile range); in addition, the unadjusted standardized mean difference and the p values for the adjusted group factor from the linear mixed model analyses are shown.